Avidity Biosciences
RNAM
#1767
Rank
NZ$19.25 B
Marketcap
NZ$124.64
Share price
0.00%
Change (1 day)
137.93%
Change (1 year)

Market capitalization of Avidity Biosciences (RNAM)

Market cap: NZ$19.25 Billion

As of March 2026 Avidity Biosciences has a market cap of NZ$19.25 Billion. This makes Avidity Biosciences the world's 1767th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences in 2026

End of year Market Cap

Year Marketcap Change
2026NZ$19.25 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$267.16 B 1,287.55%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$179.26 B 831.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
NZ$2.97 B-84.57%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
NZ$9.28 B-51.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
NZ$0.20 B-98.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
NZ$1.4 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
NZ$18.71 B-2.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
NZ$4.69 B-75.64%๐Ÿ‡บ๐Ÿ‡ธ USA